Digitalizing the design-make-test-analyze workflow in drug discovery with an electronic inventory platform.

Drug discovery is a collaborative endeavor that often involves scientists from various disciplines and global collaborators. Efficient real-time sharing and updating of design-make-test-analyze (DMTA) information remains a challenge in drug discovery, hindering timely decision-making and project advancement. We propose a novel approach utilizing existing electronic inventory systems as DMTA workflow tracking platforms. Our approach at Sygnature Discovery leverages the inherent flexibility of these systems, allowing us to tailor stages and compound information to individual project needs, resulting in significant cost savings compared with building an in-house solution or purchasing a commercial solution. Given the wide adoption of electronic inventory platforms in drug discovery, our strategy holds immense potential for easy adoption and broad application across the industry.